Literature DB >> 30409062

Knockdown of FOXP1 promotes the development of lung adenocarcinoma.

Hua Sheng1, Xiangyang Li1, Yi Xu1.   

Abstract

Lung cancer is one of the most common cancers in the world, which accounts for about 27% of all cancer deaths. However, the mechanisms underlying the pathogenesis of lung cancer cells remain largely elusive. In this study, we examined the role of the Forkhead box protein P1 (FOXP1) in lung cancer development. Our Oncomine analysis shows that FOXP1 is downregulated in lung adenocarcinoma compared with normal lung tissue. Knockdown of FOXP1 promotes the growth and invasion of PC9 and A549 cells by regulating genes of chemokine signaling molecules, including CCR1, ADCY5, GNG7, VAV3, and PLCB1. Simultaneous knockdown of CCR1 and FOXP1 attenuated FOXP1 knockdown-induced increase of lung cancer cell growth. Finally, knockdown of FOXP1 in PC9 cells promotes the tumorigenesis via CCR1 signaling in xenograft mouse model. Taken together, our data suggest that FOXP1 plays important roles in preventing lung adenocarcinoma development via suppressing chemokine signaling pathways.

Entities:  

Keywords:  FOXP1; chemokine signaling; lung cancer; proliferation

Mesh:

Substances:

Year:  2018        PMID: 30409062      PMCID: PMC6422458          DOI: 10.1080/15384047.2018.1537999

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  39 in total

Review 1.  Forkhead transcription factors: key players in development and metabolism.

Authors:  Peter Carlsson; Margit Mahlapuu
Journal:  Dev Biol       Date:  2002-10-01       Impact factor: 3.582

2.  REGgamma modulates p53 activity by regulating its cellular localization.

Authors:  Jian Liu; Guowu Yu; Yanyan Zhao; Dengpan Zhao; Ying Wang; Lu Wang; Jiang Liu; Lei Li; Yu Zeng; Yongyan Dang; Chuangui Wang; Guang Gao; Weiwen Long; David M Lonard; Shanlou Qiao; Ming-Jer Tsai; Bianhong Zhang; Honglin Luo; Xiaotao Li
Journal:  J Cell Sci       Date:  2010-12-01       Impact factor: 5.285

3.  Gallic acid suppresses the migration and invasion of PC-3 human prostate cancer cells via inhibition of matrix metalloproteinase-2 and -9 signaling pathways.

Authors:  Kuo-Ching Liu; An-Cheng Huang; Ping-Ping Wu; Hui-Yi Lin; Fu-Shin Chueh; Jai-Sing Yang; Chi-Cheng Lu; Jo-Hua Chiang; Menghsiao Meng; Jing-Gung Chung
Journal:  Oncol Rep       Date:  2011-04-15       Impact factor: 3.906

4.  Diversity of gene expression in adenocarcinoma of the lung.

Authors:  M E Garber; O G Troyanskaya; K Schluens; S Petersen; Z Thaesler; M Pacyna-Gengelbach; M van de Rijn; G D Rosen; C M Perou; R I Whyte; R B Altman; P O Brown; D Botstein; I Petersen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-13       Impact factor: 11.205

5.  Bypass mechanisms of the androgen receptor pathway in therapy-resistant prostate cancer cell models.

Authors:  Rute B Marques; Natasja F Dits; Sigrun Erkens-Schulze; Wytske M van Weerden; Guido Jenster
Journal:  PLoS One       Date:  2010-10-19       Impact factor: 3.240

6.  Somatic mutations affect key pathways in lung adenocarcinoma.

Authors:  Li Ding; Gad Getz; David A Wheeler; Elaine R Mardis; Michael D McLellan; Kristian Cibulskis; Carrie Sougnez; Heidi Greulich; Donna M Muzny; Margaret B Morgan; Lucinda Fulton; Robert S Fulton; Qunyuan Zhang; Michael C Wendl; Michael S Lawrence; David E Larson; Ken Chen; David J Dooling; Aniko Sabo; Alicia C Hawes; Hua Shen; Shalini N Jhangiani; Lora R Lewis; Otis Hall; Yiming Zhu; Tittu Mathew; Yanru Ren; Jiqiang Yao; Steven E Scherer; Kerstin Clerc; Ginger A Metcalf; Brian Ng; Aleksandar Milosavljevic; Manuel L Gonzalez-Garay; John R Osborne; Rick Meyer; Xiaoqi Shi; Yuzhu Tang; Daniel C Koboldt; Ling Lin; Rachel Abbott; Tracie L Miner; Craig Pohl; Ginger Fewell; Carrie Haipek; Heather Schmidt; Brian H Dunford-Shore; Aldi Kraja; Seth D Crosby; Christopher S Sawyer; Tammi Vickery; Sacha Sander; Jody Robinson; Wendy Winckler; Jennifer Baldwin; Lucian R Chirieac; Amit Dutt; Tim Fennell; Megan Hanna; Bruce E Johnson; Robert C Onofrio; Roman K Thomas; Giovanni Tonon; Barbara A Weir; Xiaojun Zhao; Liuda Ziaugra; Michael C Zody; Thomas Giordano; Mark B Orringer; Jack A Roth; Margaret R Spitz; Ignacio I Wistuba; Bradley Ozenberger; Peter J Good; Andrew C Chang; David G Beer; Mark A Watson; Marc Ladanyi; Stephen Broderick; Akihiko Yoshizawa; William D Travis; William Pao; Michael A Province; George M Weinstock; Harold E Varmus; Stacey B Gabriel; Eric S Lander; Richard A Gibbs; Matthew Meyerson; Richard K Wilson
Journal:  Nature       Date:  2008-10-23       Impact factor: 49.962

7.  CCR1 knockdown suppresses human non-small cell lung cancer cell invasion.

Authors:  Chang-Li Wang; Bing-Sheng Sun; Yong Tang; Hong-Qing Zhuang; Wei-Zhi Cao
Journal:  J Cancer Res Clin Oncol       Date:  2008-10-30       Impact factor: 4.553

8.  Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation.

Authors:  Cole Trapnell; Brian A Williams; Geo Pertea; Ali Mortazavi; Gordon Kwan; Marijke J van Baren; Steven L Salzberg; Barbara J Wold; Lior Pachter
Journal:  Nat Biotechnol       Date:  2010-05-02       Impact factor: 54.908

Review 9.  Chemokines in tumor progression and metastasis.

Authors:  Purvaba J Sarvaiya; Donna Guo; Ilya Ulasov; Patrik Gabikian; Maciej S Lesniak
Journal:  Oncotarget       Date:  2013-12

10.  Comprehensive molecular profiling of lung adenocarcinoma.

Authors: 
Journal:  Nature       Date:  2014-07-09       Impact factor: 49.962

View more
  13 in total

1.  FOXP1 drives osteosarcoma development by repressing P21 and RB transcription downstream of P53.

Authors:  Hanjun Li; Xiuguo Han; Shengbing Yang; Yongjie Wang; Yang Dong; Tingting Tang
Journal:  Oncogene       Date:  2021-03-14       Impact factor: 9.867

2.  Elevated MicroRNA 183 Impairs Trophoblast Migration and Invasiveness by Downregulating FOXP1 Expression and Elevating GNG7 Expression during Preeclampsia.

Authors:  Weisi Lai; Ling Yu
Journal:  Mol Cell Biol       Date:  2020-12-21       Impact factor: 4.272

3.  Comprehensive Analysis of Prognostic and immune infiltrates for FOXPs Transcription Factors in Human Breast Cancer.

Authors:  Jianing Yi; Siyi Tan; Yuanjun Zeng; Lianhong Zou; Jie Zeng; Chaojie Zhang; Luyao Liu; Peizhi Fan
Journal:  Sci Rep       Date:  2022-05-25       Impact factor: 4.996

4.  Single nucleotide polymorphisms in FOXP1 and RORA of the lymphocyte activation-related pathway affect survival of lung cancer patients.

Authors:  Hailei Du; Rui Mu; Lihua Liu; Hongliang Liu; Sheng Luo; Edward F Patz; Carolyn Glass; Li Su; Mulong Du; David C Christiani; Hecheng Li; Qingyi Wei
Journal:  Transl Lung Cancer Res       Date:  2022-05

Review 5.  Molecular networks of FOXP family: dual biologic functions, interplay with other molecules and clinical implications in cancer progression.

Authors:  Ju-Ha Kim; Jisung Hwang; Ji Hoon Jung; Hyo-Jung Lee; Dae Young Lee; Sung-Hoon Kim
Journal:  Mol Cancer       Date:  2019-12-09       Impact factor: 27.401

6.  DNA Methylation in Babies Born to Nonsmoking Mothers Exposed to Secondhand Smoke during Pregnancy: An Epigenome-Wide Association Study.

Authors:  Bernard F Fuemmeler; Mikhail G Dozmorov; Elizabeth K Do; Junfeng Jim Zhang; Carole Grenier; Zhiqing Huang; Rachel L Maguire; Scott H Kollins; Cathrine Hoyo; Susan K Murphy
Journal:  Environ Health Perspect       Date:  2021-05-19       Impact factor: 9.031

7.  FOXP4 promotes laryngeal squamous cell carcinoma progression through directly targeting LEF‑1.

Authors:  Jian Shi; Jingtian Wang; Hongkun Cheng; Shenghui Liu; Xiaowei Hao; Lili Lan; Gancun Wu; Meng Liu; Yan Zhao
Journal:  Mol Med Rep       Date:  2021-09-30       Impact factor: 2.952

8.  GNG7 and ADCY1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinoma through bioinformatic-based analyses.

Authors:  Youfu Zhang; Jinran Yang; Xuyang Wang; Xinchang Li
Journal:  Sci Rep       Date:  2021-10-14       Impact factor: 4.379

9.  Understanding the Critical Role of Glycolysis-Related lncRNAs in Lung Adenocarcinoma Based on Three Molecular Subtypes.

Authors:  Peng Cao; Bo Zhao; Yajie Xiao; Shan Hu; Kangle Kong; Peng Han; Jiaqi Yue; Yu Deng; Zhikun Zhao; Dongfang Wu; Lu Zhang; Fan Li
Journal:  Biomed Res Int       Date:  2022-02-07       Impact factor: 3.411

10.  Whole-Genome Methylation Study of Congenital Lung Malformations in Children.

Authors:  Sara Patrizi; Federica Pederiva; Adamo Pio d'Adamo
Journal:  Front Oncol       Date:  2021-06-28       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.